COLIN ANDREW HARDIN M.D. NPI 1639459860

NPI Details

Colin Andrew Hardin, M.D. is a hematology and oncology internal medicine in Grand Rapids, MI with 14 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Colin Andrew Hardin, M.D. NPI is 1639459860. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

145 MICHIGAN ST NE STE 3100
GRAND RAPIDS, MI
ZIP 49503-563
Phone: (616) 954-9800

The NPI 1639459860 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Iron level (HCPCS:83540)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Protein measurement, serum (HCPCS:84165)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Folic acid level, serum (HCPCS:82746)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Uric acid level, blood (HCPCS:84550)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Reticulated (young) platelet measurement (HCPCS:85055)
• Hospital discharge day management, more than 30 minutes (HCPCS:99239)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Hepatitis c antibody measurement (HCPCS:86803)
• Measurement of hepatitis a antibody (HCPCS:86708)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)

The enumeration date for this NPI number is 8/19/2011 and was last updated on 4/14/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: